The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Real-world outcomes and patient (pt) characteristics for the second-line (2L) treatment of gastric, esophageal, or gastroesophageal junction (GEJ) adenocarcinoma (EGAC).

Afsaneh  Barzi

Consulting or Advisory Role - bioTheranostics; Merrion

Lisa M.  Hess

Employment - Lilly

Yajun  Zhu

Employment - Lilly

Astra M.  Liepa

Employment - Lilly

Stock and Other Ownership Interests  - Amgen; Lilly

Yun  Fang

No Relationships to Disclose

Craig Heath  Kuder

Employment - Lilly

Julie  Beyrer

Employment - Lilly

Joseph  Chao

Consulting or Advisory Role - Boston Biomedical; Five Prime Therapeutics; Lilly; Merck

Speakers' Bureau - Merck

Research Funding - Merck (Inst); Novonco Therapeutics (Inst)